The government appears to be slow to announce a plan to reform the drug pricing system, which includes measures to give preferential prices for drugs that reflect the value of innovation. Although we have already held several consultative meetings with representatives of domestic and foreign pharmaceutical and biopharmaceutical companies, it is becoming increasingly late to present results on how to specifically evaluate innovation value and provide preferential drug prices.

Initially, it was expected that the government would announce a plan to improve the drug price system in September last September for new drugs. The Ministry of Health and Welfare's plan was to make a final announcement as soon as